Evidence map›Paper›PMID 21461909›Full record

ArticleInternal and emergency medicine2011

Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism.

Benilde Cosmi, Mathilde Nijkeuter, Massimo Valentino, Menno V Huisman, Libero Barozzi, Gualtiero Palareti

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Internal and emergency medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01781858 completednot on this map

Study on the Clinical Course Of Pulmonary Embolism

TypeobservationalSponsorUniversity of PadovaRan2008 to 2014Enrolled700ConditionsCardiovascular Diseases, Venous Thromboembolism, Pulmonary Hypertension
NCT05568927 completednot on this mapstarted 2022, after this paper: background citation

An Observational Cohort Study to Validate SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary Embolism

TypeobservationalSponsorUniversity of California, San DiegoRan2022 to 2025Enrolled150ConditionsPulmonary Embolism, Chronic Thromboembolic Pulmonary HypertensionArmsSEARCH algorithm
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Can thrombus age guide thrombolytic therapy?Cardiovascular diagnosis and therapy · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Benilde CosmiDepartment of Angiology and Blood Coagulation Marino Golinelli, University Hospital S. Orsola-Malpighi, Via Albertoni, 15, Bologna, Italy. benilde.cosmi@unibo.it
Mathilde Nijkeuter
Massimo Valentino
Menno V Huisman
Libero Barozzi
Gualtiero Palareti
Policlinico S.Orsola-Malpighi · ITLeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rate of resolution of a first episode of pulmonary embolism (PE) is uncertain. A baseline test indicating any residual PE is pivotal in aiding a more accurate diagnosis of recurrent PE. This study aimed to assess the rate and risk factors of residual PE with either multidetector computed tomography imaging (MDCT) or lung perfusion scan (LPS) using a cross-sectional study in which consecutive patients were enrolled with a first objectively documented episode of symptomatic PE, and who were considered for possible treatment withdrawal after at least 3 months of anticoagulation. A first cohort of patients (n = 80) underwent MDCT, while the subsequent cohort (n = 93) underwent LPS. The two cohorts had similar characteristics, and 98.3% of patients had non high-risk index PE. MDCT detected residual PE in 15% of subjects (12/80, 95% CI 8-25%) after a mean of 9 months of anticoagulation. No clinical characteristics were significantly associated with residual PE at MDCT. LPS detected residual PE in 28% (26/93, 95% CI 19-38%) of patients after a period of a mean of 9 months of anticoagulation with a significant association with increasing age and known pulmonary disease. Resolution of PE was high after a first episode of non high-risk PE treated with heparin followed by at least 3 months of anticoagulation. Age and coexistent pulmonary disease influence the presence of residual PE detected by LPS, but not by MDCT. Further studies are warranted in which the presence of residual embolism is detected by repetition of the same test that had been initially carried out.

Indexed as

Acute DiseaseAdultAgedAged, 80 and overAntifibrinolytic AgentsCross-Sectional StudiesFemaleHumansLogistic ModelsMaleMiddle AgedPerfusion ImagingPredictive Value of TestsPulmonary EmbolismTomography, X-Ray ComputedVitamin KAntifibrinolytic AgentsVitamin K

Identifiers

PMID21461909
OpenAlexW1990069285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.